share_log

EXCLUSIVE: SAB Biotherapeutics Tells Benzinga Co. Has Received An Additional $8.2M From DoD Related To Closeout Of The Discontinued COVID-19 Prototype Research And Development Contract

EXCLUSIVE: SAB Biotherapeutics Tells Benzinga Co. Has Received An Additional $8.2M From DoD Related To Closeout Of The Discontinued COVID-19 Prototype Research And Development Contract

独家:SAB Biotherapeutics 告诉本辛加公司已从国防部额外获得820万美元,与终止的 COVID-19 原型研发合同的终止有关
Benzinga Real-time News ·  2023/01/18 07:32

EXCLUSIVE: SAB Biotherapeutics Tells Benzinga Co. Has Received An Additional $8.2M From DoD Related To Closeout Of The Discontinued COVID-19 Prototype Research And Development Contract

独家:SAB Biotherapeutics 告诉本辛加公司已从国防部额外获得820万美元,与终止的 COVID-19 原型研发合同的终止有关

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发